Revenue Cycle Advisor combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule and regulatory updates thoroughly. Learn more .
Despite opposition from stakeholders, a bipartisan contingent of Congress, and the CMS advisory panel, the agency is moving forward with its plan to drastically cut payments for drugs acquired through the 340B discount program, according to the 2018 OPPS final rule.